Medi-Caps Board of Directors

Get the latest insights into the leadership at Medi-Caps. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Abhishek JainCompany Secretary & Compliance Officer
Ramesh Chandra MittalChairman
Alok K GargManaging Director
Kusum MittalNon Executive Woman Director
Ashok Omprakash AgrawalNon Executive Independent Director
Dharmendra SolankiNon Executive Independent Director
Gajendra SinghNon Executive Independent Director

Medi-Caps Share price

MEDICAPQ

31.35

0.35 (1.13%)
Last updated on 8 May, 2026 | 15:40 IST
Today's High

32.62

Today's Low

30.86

52 Week Low

21.00

52 Week High

46.99

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Medi-Caps FAQs

The board at Medi-Caps consists of experienced professionals, including Abhishek Jain, Ramesh Chandra Mittal, and others, overseeing the company’s strategic and corporate governance.

Directors at Medi-Caps are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Abhishek Jain is the current chairman at Medi-Caps.

Executive directors at Medi-Caps are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Medi-Caps adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Medi-Caps, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost